New York, NY -- (SBWIRE) -- 09/09/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding Oncolytics Biotech Inc. (NASDAQ:ONCY) and Celsion Corp. (NASDAQ:CLSN).
Oncolytics Biotech Inc. (NASDAQ:ONCY) a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers is currently up (+15.10%) on 5,052,056 shares traded after Oncolytics Biotech Inc. Announced Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer. Oncolytics Biotech Inc. (NASDAQ:ONCY) is currently up (+98.12%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Oncolytics Biotech Inc. (NASDAQ:ONCY)
Celsion Corp. (NASDAQ:CLSN) an oncology drug development company that focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology is currently down (-8.01%) on 5,441,619 shares traded after Celsion Corporation Announced Combined Clinical Data from Two Phase I Trials to be Presented at the 2013 San Antonio Breast Cancer Conference. Celsion Corp. (NASDAQ:CLSN) is currently down (-86.86%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Celsion Corp. (NASDAQ:CLSN)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)